International Myeloma Foundation
IMF Publication - Understanding SARCLISA®(isatuximab-irfc)
IMF Publication - Understanding SARCLISA®(isatuximab-irfc)
Couldn't load pickup availability
Understanding SARCLISA®(isatuximab-irfc) discusses a novel anti-CD38 monoclonal antibody that is approved for patients with relapsed and refractory myeloma. Sarclisa binds to myeloma cells to kill them directly, and also recruits other immune system cells to kill myeloma cells. You can also download a copy here: https://www.myeloma.org/resource-library/understanding-sarclisa.
-
Shipping Information
FREE SHIPPING for all tip cards and publications.
Shipping times typically take 7-14 business days. Orders totaling up to $49.99 will incur a shipping cost of $5; orders totaling $50 and up will incur a shipping cost of $10.
Currently, the IMF does not provide international shipping via our Shopify store. If you are planning to purchase IMF merchandise or to order free educational publications outside of the U.S. (including U.S. territories), please contact the IMF directly at the imf@myeloma.org or 1-818-487-7455.